| Term 
 
        | What is the mechanism of Digitalis? What are the adverse effects?What is the half life?
 |  | Definition 
 
        | Mechanism Block Na/K-ATPase-> decrease Ca/Na-> increasing cellular Ca-> Increased Inotropy Vagomimetic Adverse AV block/ Arrhythmias Color Vision Loss Gynecomastia Toxic with non-sparing Diuretics Half Life Digoxin: 40 hours Digitalis: 170 hours |  | 
        |  | 
        
        | Term 
 
        | What is the relative therapeudic index of digitalis and what is the half life? |  | Definition 
 
        | Low therapeudic index Half life- 40hrs(Digoxin), 170hrs(Digitoxin) |  | 
        |  | 
        
        | Term 
 
        | What are drugs that interact with digitalis |  | Definition 
 
        | Quinidine Non-K-sparing diuretics |  | 
        |  | 
        
        | Term 
 
        | Phosphodiesterase Inhibitors used in CHF? When are they used? What is wrong with them? What is their mechanism? |  | Definition 
 
        | Amrinone: Short IV tx because it induces hepatoxicity and nausea Milrinone: Acute HF because it has a Higher mortality than digitalis Mech: PDE 3 inhibition blocking cAMP degration |  | 
        |  | 
        
        | Term 
 
        | When is Dopamine used in HF? What is its mechanism |  | Definition 
 
        | Acute HF Mech: Peripheral Dialation, Increase Norepi at heart
 |  | 
        |  | 
        
        | Term 
 
        | What are the diuretics used in CHF What is the mechanism of the one that decreases mortality in heart failure? |  | Definition 
 
        | Hydrochlorothiazide Furosemide Spironolactone Mechanism of spironolactone: Increase NO Decrease fibrosis Decrease vasoconstriction K-sparing diuresis |  | 
        |  | 
        
        | Term 
 
        | What are the vasodialators used in CHF? Which reduces CHF mortality? When would the other be used? |  | Definition 
 
        | Nitrates: Pulm Congestion Hydralazine: Low Ventricular output BiDil(Isosorbide Dinitrate and Hydralazine) decreases mortality in African Americans |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of Nesirtide and why is it not used? |  | Definition 
 
        | B-type natriuetic Peptide-> increases cGMP Not used bc Increased short-term mortality |  | 
        |  | 
        
        | Term 
 
        | How do Ace-inhibitors or ARB effectively treat CHF |  | Definition 
 
        | Decrease Sympathetics Decrease Vasoconstriction (Afterload) Decrease Aldosterone(Preload) Decrease Remodeling   |  | 
        |  | 
        
        | Term 
 
        | What is the most effective B-Block in treating CHF, what is the proposed mechanism? |  | Definition 
 
        | Carvedilol because there is alpha block as well Decrease Sympathetic overload |  | 
        |  | 
        
        | Term 
 
        | What is the Step-wise approach to treat CHF |  | Definition 
 
        | I. Weight Reduction II. Decrease Salt III. Spironolactone IV. Ace Inhibitor V. B-blocker VI. Digitalis VII. Vasodialators |  | 
        |  | 
        
        | Term 
 
        | What drugs used to treat CHF will decrease mortality |  | Definition 
 
        | Ace-inhibitors B-blockers Spironolactone BiDil |  | 
        |  |